Common Contracts
11 similar null contracts by Adhera Therapeutics, Inc., 60 Degrees Pharmaceuticals, Inc.
original issue discount SENIOR SECURED PROMISSORY NOTEAdhera Therapeutics, Inc. • June 29th, 2023 • Pharmaceutical preparations
THIS ORIGINAL ISSUE DISCOUNT SENIOR SECURED PROMISSORY NOTE is duly authorized and validly issued at an original issue discount by ADHERA THERAPEUTICS, INC., a Delaware corporation (the “Company”) (the “Note”).
ORIGINAL ISSUE DISCOUNT PROMISSORY NOTE60 Degrees Pharmaceuticals, Inc. • May 19th, 2023 • Pharmaceutical preparations
THIS ORIGINAL ISSUE DISCOUNT CONVERTIBLE PROMISSORY NOTE is duly authorized and validly issued at a 10% original issue discount by 60° Pharmaceuticals, Inc. (the “Company”) (the “Note”).
ORIGINAL ISSUE DISCOUNT PROMISSORY NOTE60 Degrees Pharmaceuticals, Inc. • May 19th, 2023 • Pharmaceutical preparations
THIS ORIGINAL ISSUE DISCOUNT CONVERTIBLE PROMISSORY NOTE is duly authorized and validly issued at a 10% original issue discount by 60° Pharmaceuticals, Inc. (the “Company”) (the “Note”).
NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE...60 Degrees Pharmaceuticals, Inc. • May 19th, 2023 • Pharmaceutical preparations
THIS ORIGINAL ISSUE DISCOUNT CONVERTIBLE PROMISSORY NOTE is duly authorized and validly issued at a 10% original issue discount by 60° Pharmaceuticals, Inc. (the “Company”) (the “Note”).
NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE...60 Degrees Pharmaceuticals, Inc. • May 19th, 2023 • Pharmaceutical preparations
THIS ORIGINAL ISSUE DISCOUNT CONVERTIBLE PROMISSORY NOTE is duly authorized and validly issued at a 10% original issue discount by 60° Pharmaceuticals, Inc. (the “Company”) (the “Note”).
ORIGINAL ISSUE DISCOUNT PROMISSORY NOTE60 Degrees Pharmaceuticals, Inc. • May 19th, 2023 • Pharmaceutical preparations
THIS ORIGINAL ISSUE DISCOUNT CONVERTIBLE PROMISSORY NOTE is duly authorized and validly issued at a 10% original issue discount by 60° Pharmaceuticals, Inc. (the “Company”) (the “Note”).
original issue discount SENIOR SECURED PROMISSORY NOTEAdhera Therapeutics, Inc. • May 5th, 2023 • Pharmaceutical preparations
THIS ORIGINAL ISSUE DISCOUNT SENIOR SECURED PROMISSORY NOTE is duly authorized and validly issued at an original issue discount by ADHERA THERAPEUTICS, INC., a Delaware corporation (the “Company”) (the “Note”).
original issue discount SENIOR SECURED PROMISSORY NOTEAdhera Therapeutics, Inc. • May 4th, 2023 • Pharmaceutical preparations
THIS ORIGINAL ISSUE DISCOUNT SENIOR SECURED PROMISSORY NOTE is duly authorized and validly issued at an original issue discount by ADHERA THERAPEUTICS, INC., a Delaware corporation (the “Company”) (the “Note”).
original issue discount SENIOR SECURED PROMISSORY NOTEAdhera Therapeutics, Inc. • March 8th, 2023 • Pharmaceutical preparations
THIS ORIGINAL ISSUE DISCOUNT SENIOR SECURED PROMISSORY NOTE is duly authorized and validly issued at an original issue discount by ADHERA THERAPEUTICS, INC., a Delaware corporation (the “Company”) (the “Note”).
original issue discount SENIOR SECURED PROMISSORY NOTEAdhera Therapeutics, Inc. • February 23rd, 2023 • Pharmaceutical preparations
THIS ORIGINAL ISSUE DISCOUNT SENIOR SECURED PROMISSORY NOTE is duly authorized and validly issued at an original issue discount by ADHERA THERAPEUTICS, INC., a Delaware corporation (the “Company”) (the “Note”).
original issue discount SENIOR SECURED PROMISSORY NOTEAdhera Therapeutics, Inc. • May 16th, 2022 • Pharmaceutical preparations
THIS ORIGINAL ISSUE DISCOUNT SENIOR SECURED PROMISSORY NOTE is duly authorized and validly issued at an original issue discount by ADHERA THERAPEUTICS, INC., a Delaware corporation (the “Company”) (this “Note”).
